Literature DB >> 7633147

Comparison of different indices of dietary control in phenylketonuria.

A Rupp1, P Burgard.   

Abstract

Ten different indices of dietary control (IDCs) applied frequently to investigate compliance of phenylketonuric patients were calculated for a set of blood phenylalanine levels for 98 patients in the German Collaborative Study of Children Treated for Phenylketonuria during their first 9 years of life. The results were compared for similarities and differences. Cluster analysis of longitudinal phenylalanine data was introduced to analyse phenylalanine blood levels independent of a priori defined criteria of classification. Three groups of good, intermediate and poor long-term dietary control were identified. Internal validation of the IDCs was corroborated by the high inter-correlations of the indices. External validity was determined by the inter-relations of the WISC-R IQ and the IDCs. The different algorithms of IDCs suggest different clinical conclusions. To facilitate comparisons of results of future research, IDCs should be standardized.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633147     DOI: 10.1111/j.1651-2227.1995.tb13686.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Executive function in treated phenylketonuria as measured by the one-back and two-back versions of the continuous performance test.

Authors:  P Griffiths; R Campbell; P Robinson
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

2.  Wechsler subscale IQ and subtest profile in early treated phenylketonuria.

Authors:  P V Griffiths; C Demellweek; N Fay; P H Robinson; D C Davidson
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

3.  Intelligence patterns among children with high-functioning autism, phenylketonuria, and childhood head injury.

Authors:  M Dennis; L Lockyer; A L Lazenby; R E Donnelly; M Wilkinson; W Schoonheyt
Journal:  J Autism Dev Disord       Date:  1999-02

4.  Neuropsychological outcome of experimental manipulation of phenylalanine intake in treated phenylketonuria.

Authors:  P Griffiths; N Ward; A Harvie; F Cockburn
Journal:  J Inherit Metab Dis       Date:  1998-02       Impact factor: 4.982

5.  Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.

Authors:  E Schmidt; P Burgard; A Rupp
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

6.  Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria.

Authors:  P Burgard; E Schmidt; A Rupp; W Schneider; H J Bremer
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

7.  Intelligence and professional career in young adults treated early for phenylketonuria.

Authors:  H Schmidt; P Burgard; J Pietz; A Rupp
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

8.  Phenylalanine hydroxylase genotypes, predicted residual enzyme activity and phenotypic parameters of diagnosis and treatment of phenylketonuria.

Authors:  P Burgard; A Rupp; D S Konecki; F K Trefz; H Schmidt; U Lichter-Konecki
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

9.  Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.

Authors:  P Cechák; L Hejcmanová; A Rupp
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.